Harbour Investments, Inc. Night Hawk Biosciences, Inc. Transaction History

Harbour Investments, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 22, 2024	BUY	$0.15 - $0.45 $0 - $0	0 New	0 $0
Q4 2023 Feb 16, 2024	BUY	$0.26 - $0.51 $0 - $0	0 New	0 $0
Q3 2023 Nov 15, 2023	BUY	$0.5 - $0.72 $0 - $0	0 New	0 $0
Q2 2023 Aug 14, 2023	BUY	$0.62 - $0.87 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$0.83 - $1.24 $0 - $0	0 New	0 $0
Q4 2022 Feb 15, 2023	SELL	$0.77 - $1.62 $549 - $1,156	-714 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$3.04 - $6.01 $42 - $84	-14 Reduced 1.92%	714 $2,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $5 - $7	1 Added 0.14%	728 $4,000
Q1 2021 Aug 17, 2021	BUY	$5.67 - $12.54 $4,122 - $9,116	727 New	727 $5,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.